Martin Brenner - 21 Jun 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Interim Chief Executive Officer and Chief Scientific Officer
Signature
/s/ Martin Brenner
Issuer symbol
IBIO
Transactions as of
21 Jun 2023
Net transactions value
-$2,849
Form type
4
Filing time
22 Jun 2023, 09:28:52 UTC
Previous filing
24 May 2023
Next filing
27 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Sale $2,626 -3,859 -1.5% $0.6805 253,736 21 Jun 2023 Direct F1
transaction IBIO Common Stock Sale $155 -225 -0.09% $0.6867 253,511 21 Jun 2023 Direct F1
transaction IBIO Common Stock Sale $68.32 -100 -0.04% $0.6832 253,411 21 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

Remarks:

Interim Chief Executive Officer and Chief Scientific Officer